- Home
- JANX vs COCO Comparison
JANX vs COCO Comparison
Compare JANX & COCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- COCO
- Stock Information
- Founded
- JANX 2017
- COCO 2004
- Country
- JANX United States
- COCO United States
- Employees
- JANX N/A
- COCO N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- COCO Beverages (Production/Distribution)
- Sector
- JANX Health Care
- COCO Consumer Staples
- Exchange
- JANX Nasdaq
- COCO Nasdaq
- Market Cap
- JANX 1.6B
- COCO 1.8B
- IPO Year
- JANX 2021
- COCO 2021
- Fundamental
- Price
- JANX $26.37
- COCO $35.01
- Analyst Decision
- JANX Strong Buy
- COCO Buy
- Analyst Count
- JANX 7
- COCO 7
- Target Price
- JANX $94.29
- COCO $35.57
- AVG Volume (30 Days)
- JANX 974.6K
- COCO 722.3K
- Earning Date
- JANX 05-20-2025
- COCO 04-30-2025
- Dividend Yield
- JANX N/A
- COCO N/A
- EPS Growth
- JANX N/A
- COCO 11.36
- EPS
- JANX N/A
- COCO 1.01
- Revenue
- JANX $10,588,000.00
- COCO $535,236,000.00
- Revenue This Year
- JANX N/A
- COCO $12.42
- Revenue Next Year
- JANX $250.58
- COCO $10.73
- P/E Ratio
- JANX N/A
- COCO $34.64
- Revenue Growth
- JANX 30.99
- COCO 8.01
- 52 Week Low
- JANX $22.52
- COCO $23.56
- 52 Week High
- JANX $71.71
- COCO $40.32
- Technical
- Relative Strength Index (RSI)
- JANX 39.10
- COCO 62.64
- Support Level
- JANX $31.34
- COCO $29.74
- Resistance Level
- JANX $33.97
- COCO $35.70
- Average True Range (ATR)
- JANX 1.94
- COCO 1.49
- MACD
- JANX -0.52
- COCO 0.57
- Stochastic Oscillator
- JANX 22.76
- COCO 88.42
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About COCO The Vita Coco Company Inc.
The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.